Trial · NCT01353313

Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Overall Study	STARTED	Hydrocortisone	398
Overall Study	STARTED	Placebo	402
Overall Study	Completed Assessment for Neurodevelopmental Impairment	Hydrocortisone	321
Overall Study	Completed Assessment for Neurodevelopmental Impairment	Placebo	318
Overall Study	Died After Discharge	Hydrocortisone	8
Overall Study	Died After Discharge	Placebo	6
Overall Study	Died Before Discharge	Hydrocortisone	35
Overall Study	Died Before Discharge	Placebo	40
Overall Study	Survived to Discharge	Hydrocortisone	363
Overall Study	Survived to Discharge	Placebo	362
Overall Study	COMPLETED	Hydrocortisone	364
Overall Study	COMPLETED	Placebo	364
Overall Study	NOT COMPLETED	Hydrocortisone	34
Overall Study	NOT COMPLETED	Placebo	38

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01353313/flow